B

Background Contamination
Background contamination can be confused with constituents in samples being analyzed.

Bioavailability
Bioavailabilty refers to the rate and amount of drug absorption.

Bioinformatics
Bioinformatics is a fast-growing field producing new advances in the prevention, diagnosis and treatment of different genetic diseases

Biosafety Levels
Biologic agents and their containment facilities are classified according to their level of risk to health and safety.

Biosimilar Drugs
Biosimilar drugs must be "highly similar" to biologic drugs but industry experts say it is a misnomer to call them biogenerics.

Black box warning
It is the most serious medication warning required by FDA.

Biobetter
A biobetter is a recombinant protein drug in the same class as an existing biopharmaceutical but is an improved over the original drug.

Biologic License Application (BLA)
Definition of the term Biologic License Application.